Global Overactive Bladder Therapeutics Market 2014-2018 is the latest addition to Sandlerresearch.org industry research reports collection.
Overactive bladder is a urological condition associated with urination problems. The condition is characterized by bladder storage symptoms such as urgency, change in frequency of urination, nocturia, or urinary incontinence. It is also known as overactive bladder syndrome. Although it is not a life-threatening condition, it is often stigmatized and debilitating. Some of the important symptoms of overactive bladder are urinary urgency and incontinence. The pathophysiology of overactive bladder is not characterized completely. The symptoms of overactive bladder can last for a lifetime or it can relapse and remit. The problem can be resolved through treatment. Overactive bladder can affect a person irrespective of the gender. The reason is the abnormal contraction of the urinary detrusor muscle of the bladder. In addition, overactive bladder can be related to neurological diseases such as Parkinson’s disease and multiple sclerosis.
Analysts forecast the Global Overactive Bladder Therapeutics market to grow at a CAGR of 1.14 percent over the period 2013-2018.
Single User License of the report is Available at US $2500
The report recognizes the following companies as the key players in the Global Overactive Bladder Therapeutics Market: Actavis plc., Allergan Inc., Astellas Pharma Inc. and Pfizer Inc.
Other Prominent Vendors in the market are: Addex Therapeutics, AltheRx Pharmaceuticals, American Oriental Bioengineering, Antares Pharma, Apogepha Arzneimittel, Auxilium Pharmaceuticals, Bayer, Elbion, FemmePharma, Ferring Pharmaceuticals, GlaxoSmithKline, Hisamitsu Pharmaceutical, Hydra Biosciences, Ion Channel Innovations, Ipsen, Janssen, Kissei Pharma, Kwang Dong Pharmaceutical, KYORIN Pharma, Laboratorios SALVAT, LG Life Sciences, Lipella Pharmaceuticals, Merck, Motif BioSciences, Mylan, Novartis, Ono Pharmaceuticals, Ranbaxy Laboratories, Recordati, Sanofi, Sunovion, Takeda Pharmaceutical, Taris BioMedical, Teva Pharmaceutical, TheraVida, Toray Industries and Urigen Pharmaceuticals.
One major trend emerging in this market is the increase in awareness about overactive bladder syndrome. It results in an increase in the consumption of medications, thereby, contributing to the growth of the market.
Order a copy of this report at (Prices start at US $2500 for a single user PDF) http://www.sandlerresearch.org/purchase?rname=27161 .
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Overactive Bladder Therapeutics market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various generic and branded therapies used in the treatment of overactive bladder, which include:
- Anti-muscarinic Agent
- Beta-3-Adrenergic Receptor Agonist
Global Overactive Bladder Therapeutics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Overactive Bladder Therapeutics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Further, the report states that one of the major challenges that the market faces is the lack of awareness about micromolding technology. There is a lack of awareness in the developing countries in regions such as Latin America, the Middle East, and South Asia about the benefits of using micromolded polymers.
According to the report, the major driving factor of the market is the rise in the geriatric population suffering from various diseases, which are at risk of developing overactive bladder syndrome. This results in an increase in the consumption of drugs for overactive bladder, thereby, boosting growth.
Further, the report states that the difficulty in diagnosis is a major challenge to the growth of the market. It results in fewer treatment-seeking patients, which, in turn, restrains the growth of the market. The diagnosis is done through clinical examination and a series of diagnostic tests to rule out the possibilities of bladder cancer, urinary tract infection, and benign prostatic hyperplasia.
Table of Contents
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
04. Product Profiles05. Market Research Methodology
07. Market Landscape
08. Market Segmentation by Molecule Type
09. Market Segmentation by Route of Administration
10. Market Segmentation by Class of drugs
11. Market Segmentation by Dosage Form
12. Rate of Incidence and Prevalence
13. Geographical Segmentation
14. Buying Criteria
15. Market Growth Drivers
16. Drivers and their Impact
17. Market Challenges
18. Impact of Drivers and Challenges
19. Market Trends
20. Trends and their Impact
21. Vendor Landscape
23. Key Vendor Analysis
24. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Overactive Bladder Therapeutics Market 2013-2018 (US$ billion)
Exhibit 3: Global Overactive Bladder Therapeutics Market Segmentation by Molecule Type
Exhibit 4: Global Overactive Bladder Therapeutics Market Segmentation by Molecule Type 2013
Exhibit 5: Global Overactive Bladder Therapeutics Market Segmentation by Route of Administration
Exhibit 6: Global Overactive Bladder Therapeutics Market Segmentation by Route of Administration 2013
Exhibit 7: Global Overactive Bladder Therapeutics Market Segmentation by Class of Drugs
Exhibit 8: Global Overactive Bladder Therapeutics Market Segmentation by Class of Drugs 2013
Exhibit 9: Global Overactive Bladder Therapeutics Market Segmentation by Dosage Form
Exhibit 10: Global Overactive Bladder Therapeutics Market Segmentation by Dosage Form 2013
View all 37 Exhibits
Have any Query on the Report get your Queries Resolved at http://www.sandlerresearch.org/inquire-before-buying?rname=27161 .
Sandlerresearch.org (http://www.sandlerresearch.org) is an online market research store for research reports on multiple industries. These reports provide market analysis, trends and opportunities and forecast about industries that helps to make a right decision for the business.